Is nuclear factor kappa-B the missing link between inflammation, cancer and alteration in hepatic drug metabolism in patients with cancer?-Reference-Cited by-同舟云学术

Is nuclear factor kappa-B the missing link between inflammation, cancer and alteration in hepatic drug metabolism in patients with cancer?

Published:2006-04 Issue:6 Volume:42 Page:785-792
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Assenat Eric,Gerbal-chaloin Sabine,Maurel Patrick,Vilarem Marie José,Pascussi Jean Marc

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference93 articles.

1. The role of human cytochrome P450 enzymes in the metabolism of anticancer agents: implications for drug interactions;Kivisto;Br J Clin Pharmacol,1995

2. Development of a substrate-activity based approach to identify the major human liver P-450 catalysts of cyclophosphamide and ifosfamide activation based on cDNA-expressed activities and liver microsomal P-450 profiles;Roy;Drug Metab Dispos,1999

3. Direct retroviral delivery of human cytochrome P450 2B6 for gene-directed enzyme prodrug therapy of cancer;Kan;Cancer Gene Ther,2001

4. Clinical relevance of genetic polymorphisms in the human CYP2C subfamily;Goldstein;Br J Clin Pharmacol,2001

5. Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers, and inhibitors;Rendic;Drug Metab Rev,1997

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of Cytochrome P450 2C9 in COVID-19 Treatment: Current Status and Future Directions;European Journal of Drug Metabolism and Pharmacokinetics;2023-04-24

2. Deregulation of signaling pathways controlling cell survival and proliferation in cancer cells alters induction of cytochrome P450 family 1 enzymes;Toxicology;2021-09

3. Disease-drug and drug-drug interaction in COVID-19: Risk and assessment;Biomedicine & Pharmacotherapy;2021-07

4. Cytochrome P450-mediated drug interactions in COVID-19 patients: Current findings and possible mechanisms;Medical Hypotheses;2020-11

5. Disrupted hepatic pentose phosphate pathway directly participates in and indirectly promotes CYP3A reduction: A new strategy for CYP3A‐mediated drug hepatotoxicity;British Journal of Pharmacology;2020-01-29